Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big ClaimThe Motley Fool • 06/07/24
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing ToolGlobeNewsWire • 05/29/24
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending StockZacks Investment Research • 05/23/24
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical IndustryGlobeNewsWire • 05/13/24
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/24
Recursion Provides Business Updates and Reports First Quarter 2024 Financial ResultsGlobeNewsWire • 05/09/24
Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 05/03/24
Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 05/02/24
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9GlobeNewsWire • 05/02/24
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood LovesThe Motley Fool • 04/27/24